ZJYL — Jin Medical International Balance Sheet
0.000.00%
Last trade - 00:00- $12.77m
- $1.91m
- $20.69m
Annual balance sheet for Jin Medical International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.73 | 7.07 | 16.7 | 26.8 | 29.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.98 | 4.25 | 8.5 | 8.78 | 6.07 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 19.4 | 18.9 | 31.1 | 42.8 | 44.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.11 | 1.63 | 1.48 | 1.72 | 7.98 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 21.9 | 20.9 | 32.9 | 45.8 | 53.4 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.87 | 5.7 | 8.92 | 17.2 | 23.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.87 | 5.7 | 8.92 | 17 | 23.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14 | 15.2 | 24 | 28.8 | 29.6 |
| Total Liabilities & Shareholders' Equity | 21.9 | 20.9 | 32.9 | 45.8 | 53.4 |
| Total Common Shares Outstanding |